SCHEMBL12412082

SCHEMBL12412082

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)ccnc2cc1OCC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 15/20 0.56
FGFR1 P11362 4/20 0.56
FGFR2 P21802 3/20 0.56
FGFR3 P22607 3/20 0.56
FLT1 P17948 5/20 0.55
FLT4 P35916 5/20 0.55
KDR P35968 5/20 0.55
RET P07949 3/20 0.55
PDGFRB P09619 2/20 0.55
KIT P10721 2/20 0.55
PDGFRA P16234 2/20 0.55
RIPK2 O43353 1/20 0.55
ERN1 O75460 1/20 0.55
STK10 O94804 1/20 0.55
MAP3K6 O95382 1/20 0.55
ABL1 P00519 1/20 0.55
ESR1 P03372 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
BCR P11274 1/20 0.55
NQO2 P16083 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12412088 0.94 FGFR4 (0.55) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12411291 0.92 FGFR4 (0.55) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12673672 0.91 FGFR4 (0.58) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12412085 0.91 FGFR4 (0.59) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL13613075 0.90 FGFR4 (0.58) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12412059 0.90 FGFR4 (0.70) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12412325 0.90 FGFR4 (0.59) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL1894530 0.90 FGFR4 (0.56) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12412326 0.88 FGFR4 (0.57) FGFR4FGFR1FGFR2FGFR3FLT1
SCHEMBL12412081 0.86 FGFR4 (0.59) FGFR4FGFR1FGFR2FGFR3FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 FGFR4 2049/4885FGFR1 499/4885FGFR2 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.